AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Applied Materials
AMAT
|
+$1.11B |
| 2 |
Walt Disney
DIS
|
+$920M |
| 3 |
ILOW
AB International Low Volatility Equity ETF
ILOW
|
+$784M |
| 4 |
Broadcom
AVGO
|
+$771M |
| 5 |
United Rentals
URI
|
+$751M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$1.19B |
| 2 |
NVIDIA
NVDA
|
+$998M |
| 3 |
Edwards Lifesciences
EW
|
+$881M |
| 4 |
CrowdStrike
CRWD
|
+$663M |
| 5 |
Adobe
ADBE
|
+$599M |
Sector Composition
| 1 | Technology | 28.34% |
| 2 | Healthcare | 15.32% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Financials | 9.64% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
3051
DELISTED
Inozyme Pharma
INZY
| $183K | ﹤0.01% |
34,990
+2,340
| +7% | +$12.2K |
|
3052
CVRx
CVRX
$204M
| $182K | ﹤0.01% |
20,670
| – | – |
|
3053
Melco Resorts & Entertainment
MLCO
$3.75B
| $180K | ﹤0.01% |
23,057
-622
| -3% | -$4.85K |
|
3054
Denison Mines
DNN
$2.13B
| $179K | ﹤0.01% |
97,678
| – | – |
|
3055
Generation Bio
GBIO
$39.3M
| $178K | ﹤0.01% |
7,216
| – | – |
|
|
SRTA
3056
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$327M
| $177K | ﹤0.01% |
60,070
+7,490
| +14% | +$22K |
|
3057
Holley
HLLY
$451M
| $174K | ﹤0.01% |
59,070
+4,510
| +8% | +$13.3K |
|
|
SVM
3058
Silvercorp Metals
SVM
$1.09B
| $174K | ﹤0.01% |
39,800
+5,000
| +14% | +$21.9K |
|
3059
The RealReal
REAL
$948M
| $168K | ﹤0.01% |
53,400
+1,290
| +2% | +$4.05K |
|
|
AEVA
3060
Aeva Technologies
AEVA
$779M
| $165K | ﹤0.01% |
50,155
+3,680
| +8% | +$12.1K |
|
3061
LSI Industries
LYTS
$715M
| $163K | ﹤0.01% |
+10,110
| New | +$163K |
|
|
NREF
3062
NexPoint Real Estate Finance
NREF
$270M
| $162K | ﹤0.01% |
10,390
+370
| +4% | +$5.78K |
|
3063
Foghorn Therapeutics
FHTX
$326M
| $162K | ﹤0.01% |
17,380
+2,790
| +19% | +$26K |
|
3064
ProKidney
PROK
$292M
| $162K | ﹤0.01% |
84,230
| – | – |
|
|
THRD
3065
DELISTED
Third Harmonic Bio
THRD
| $162K | ﹤0.01% |
+11,930
| New | +$162K |
|
3066
Gambling.com
GAMB
$294M
| $159K | ﹤0.01% |
15,890
+1,430
| +10% | +$14.3K |
|
3067
Acacia Research
ACTG
$326M
| $157K | ﹤0.01% |
33,770
+2,650
| +9% | +$12.3K |
|
3068
American Vanguard Corp
AVD
$163M
| $157K | ﹤0.01% |
29,620
| – | – |
|
|
AGEN
3069
Agenus
AGEN
$136M
| $157K | ﹤0.01% |
28,620
| – | – |
|
3070
PB Bankshares
PBBK
$46.8M
| $156K | ﹤0.01% |
+10,088
| New | +$156K |
|
|
BLUE
3071
DELISTED
bluebird bio
BLUE
| $153K | ﹤0.01% |
14,727
| – | – |
|
3072
Clarus
CLAR
$150M
| $152K | ﹤0.01% |
33,824
+2,660
| +9% | +$12K |
|
3073
Cardlytics
CDLX
$48.5M
| $151K | ﹤0.01% |
47,310
| – | – |
|
3074
Entravision Communication
EVC
$227M
| $151K | ﹤0.01% |
73,070
+4,260
| +6% | +$8.82K |
|
|
EXK
3075
Endeavour Silver
EXK
$1.74B
| $151K | ﹤0.01% |
38,380
| – | – |
|